VMP 323887008

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Cefalexin 125mg/5ml oral suspension
BNF code 0501021L0AAACAC
Virtual Therapeutic Moiety Cefalexin
Basis of preferred name pINN - Proposed International Non-proprietary Name
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure spoonful
Virtual Product Ingredient
Ingredient Cefalexin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Oral suspension
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Cefalexin 125mg/5ml oral suspension (A A H Pharmaceuticals Ltd)
Cefalexin 125mg/5ml oral suspension (Alliance Healthcare (Distribution) Ltd)
Cefalexin 125mg/5ml oral suspension (DE Pharmaceuticals)
Cefalexin 125mg/5ml oral suspension (Flynn Pharma Ltd)
Cefalexin 125mg/5ml oral suspension (Medihealth (Northern) Ltd)
Cefalexin 125mg/5ml oral suspension (Phoenix Healthcare Distribution Ltd)
Cefalexin 125mg/5ml oral suspension (Sigma Pharmaceuticals Plc)
Cefalexin 125mg/5ml oral suspension (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Cefalexin 125mg/5ml oral suspension 100 ml

dm+d data retrieved from TRUD: release NHSBSA_1.4.0_20230130000001, imported on 31st January 2023 at 03:57:13.